Full text is available at the source.
Abstract
Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used for glycemic control and chronic weight management.
- GLP-1 receptor agonists may help improve blood sugar levels in individuals with diabetes.
- These medications are associated with weight loss in patients managing obesity.
- There is increasing interest in the patterns of spending and affordability related to GLP-1 receptor agonists.
- Understanding these financial aspects could influence patient access to these treatments.
Simplified